The majority (60%) showed concordant fold changes (Fig. 6), indicating that a large proportion of the up- and down-regulated genes in the Ctcf+/− cells were also up- and down-regulated, respectively, in the mouse liver tumors. The gene discussed is CTCF; the disease is Neoplasm of the liver.